Atlas Trials

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT03737370 · COMPLETED

Trial details

NCT number
NCT03737370
Sponsor
Tufts Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castrate Resistant Prostate Cancer
Start date
2018-01-30
Primary completion
2024-12-31
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.